approval · primary record
LENALIDOMIDE
FDA · NDA · 2026-07-22
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Action date | 2026-07-22 |
| Brand | REVLIMID |
| Sponsor | BRISTOL MYERS SQUIBB |
| Route | ORAL |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:33:55.109Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:LENALIDOMIDE:2026-07-22
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.